| Dr Michael M Kim, MD | |
|
2525 Nw Lovejoy St Ste 402, Portland, OR 97210-2865 | |
| (503) 575-1910 | |
| Not Available |
| Full Name | Dr Michael M Kim |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology - Facial Plastic Surgery |
| Location | 2525 Nw Lovejoy St Ste 402, Portland, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689720468 | NPI | - | NPPES |
| 433505 | Medicaid | AZ | |
| 218503 | Medicaid | OR | |
| 807968400 | Medicaid | ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YS0123X | Otolaryngology - Facial Plastic Surgery | MD27979 (Oregon) | Primary |
| 207YS0123X | Otolaryngology - Facial Plastic Surgery | 42031 (Arizona) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael M Kim, MD 2525 Nw Lovejoy St Ste 402, Portland, OR 97210-2865 Ph: (503) 575-1910 | Dr Michael M Kim, MD 2525 Nw Lovejoy St Ste 402, Portland, OR 97210-2865 Ph: (503) 575-1910 |
News Archive
The surface characteristics of nanoscaffolds made by nanotechnology are more similar to the three-dimensional topological structure of the extracellular matrix and the effects on the biological behaviors of cells and tissue repair are more beneficial.
Incyte Corporation today announced the closing of its public offering of 20,700,000 shares of its common stock at a price to the public of $6.75 per share, which includes 2,700,000 shares sold upon exercise by the underwriters of their option to purchase additional shares.
Back when Cody Gabbard was shooting heroin, his only significant human contact was with others in the throes of addiction, who only cared to see him when he had drugs.
Colorectal cancer (CRC) is the second leading cause of cancer-related death in the Western world. Fortunately physicians today have an abundance of drug therapies available to improve survival length for more advanced cancer patients. Now the discovery of genetic biomarkers relevant to CRC means that targeted personalised medication is increasingly common.
The risk of Sudden Infant Death Syndrome (SIDS), the third leading cause of infant death, may be lowered through the use of a pacifier.
› Verified 5 days ago
David Wei Kuo Lin, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 3600 N Interstate Ave, Interstate Medical Office Central, Portland, OR 97227 Phone: 503-331-6085 | |
Mr. Michael Lee Mcdonald, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 10101 Se Main St, # 2004, Portland, OR 97216 Phone: 503-257-3204 Fax: 503-255-7208 | |
Dr. Duane Allen Lundeberg, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 2222 Nw Lovejoy St, Suite #622, Portland, OR 97210 Phone: 503-229-8455 Fax: 503-229-7028 | |
Brian Jacob Stater, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 9155 Sw Barnes Rd Ste 536, Portland, OR 97225 Phone: 503-935-8100 Fax: 503-935-8110 | |
Dr. Edsel Uisuk Kim, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 9155 Sw Barnes Rd Ste 536, Portland, OR 97225 Phone: 503-935-8100 Fax: 503-935-8110 | |
James Isaac Cohen, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 3181 Sw Sam Jackson Park Rd, Ohsu Pv-01, Portland, OR 97239 Phone: 503-494-5355 Fax: 503-494-4631 | |
Dr. Larry Richard Thomas, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2222 Nw Lovejoy St, Suite #622, Portland, OR 97210 Phone: 503-229-8455 Fax: 503-229-7028 |